IVUS-guided emergency intervention in STEMI patients with high thrombus burden significantly reduced the number of implanted stents compared to non-IVUS guidance (P < 0.05), with similar MACE rates.
RCT (n=80)
randomly assigned
p-value: p=> 0.05
PURPOSE: This study aimed to examine the application of intravascular ultrasound (IVUS) in ST-segment elevation myocardial infarction (STEMI) patients with high thrombus burden (thrombus grade ≥3) undergoing emergency diagnosis and primary percutaneous coronary intervention. METHODS: Eighty STEMI patients were enrolled and randomly assigned to the IVUS-guided group (38 patients) or non-IVUS group (42 patients). Stent implantation was performed in non-IVUS group patients. IVUS group patients were further divided into low-risk and high-risk patients on the basis of IVUS evaluation for determining whether stenting should be performed. Major adverse cardiac event (MACE) rates, changes in the left ventricular end-diastolic diameter (LVEDD) and ejection fraction (EF) values, and stent numbers were examined during hospitalization, and follow-up was performed at 1, 3, 6, and 12 months postoperatively. RESULTS: During hospitalization, there were no significant differences in the MACE rates, LVEDD, and EF values and in the follow-up outcomes at 1, 3, 6, and 12 months postoperatively among the patients in the 2 groups (P > 0.05). A significantly lower number of stents were implanted in the IVUS group than in the non-IVUS group patients (P < 0.05). CONCLUSION: During the IVUS-guided emergency intervention, enhanced antithrombotic therapy and best medical care for low-risk STEMI patients may be feasible.
Wang et al. (Tue,) conducted a rct in ST-segment elevation myocardial infarction (STEMI) with high thrombus burden (n=80). IVUS-guided emergency intervention vs. non-IVUS guided stent implantation was evaluated on Major adverse cardiac event (MACE) rates, changes in LVEDD and EF values, and stent numbers (p=> 0.05). IVUS-guided emergency intervention in STEMI patients with high thrombus burden significantly reduced the number of implanted stents compared to non-IVUS guidance (P < 0.05), with similar MACE rates.